Showing results (31-40 of 6,211) with videos related to
Sort By:
Pageof 622
Computational Intelligence and Neuroscience|July 11, 2022
The Innovation of College Students' Ideological and Political Education under the Intelligent Environment of Internet of ThingsXia WangMethods in Molecular Biology (Clifton, N.J.)|February 12, 2017
Statistical Assessment of QC Metrics on Raw LC-MS/MS DataXia WangScientific Reports|November 29, 2025
High-dimensional continuous action space control via trust region optimized deep reinforcement learningXia WangBMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.American Journal of Translational Research|February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatmentDejuan Kong, Elisabeth Heath, Wei Chen, et al.BMC Cancer|May 16, 2015
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesisFélix Fernández Madrid, Marie-Claire Maroun, Ofelia A Olivero, et al.The Breast Journal|April 27, 2019
Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patientsAli Amro, Yalei Chen, Renee Barry, et al.BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.Plos One|March 24, 2012
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMDejuan Kong, Elisabeth Heath, Wei Chen, et al.Annals of Surgical Oncology|April 22, 2018
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant ChemotherapyKo Un Park, Yalei Chen, Dhananjay Chitale, et al.Pageof 622